Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
, , , , , e
20 ott 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 20 ott 2022
Pagine: 265 - 270
DOI: https://doi.org/10.2478/enr-2022-0028
Parole chiave
© 2022 Suleyman Baldane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Baldane, Suleyman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Celik, M
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Kebapcilar, Levent
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Ipekci, Suleyman Hilmi
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Abusoglu, Sedat
Department Biochemistry, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Yilmaz, Huseyin
Department of Surgery, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Alptekin, Husnu
Department of Surgery, Faculty of Medicine, Selcuk UniversityKonya, Turkey